Seasonal variation of pharmaceutically active compounds in surface (Tagus River) and tap water (Central Spain)

Environmental Science and Pollution Research

Volumn 20, Issue 3, 2013, Pages 1396-1412

  Valcarcel Y ^a   Alonso, S González ^a   Rodriguez Gil J L ^b   Castano A ^c   Montero, J C ^f   Criado Alvarez, J J ^d   Miron I J ^e   Catala M ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b UNIVERSITY OF GUELPH   (Canada)

^c Instituto de Salud Carlos III   (Spain)

^d Castilla La Mancha Health Service (SESCAM)   (Spain)

^e University of Castile La Mancha   (Spain)

^f Health Science Institute of Castilla La Mancha   (Spain)

Author keywords

Drinking water; Mediterranean region; Pharmaceuticals; Seasonal variation; Spain; Surface water

Indexed keywords

AQUATIC ENVIRONMENT; CONCENTRATION (COMPOSITION); DRINKING WATER; ENVIRONMENTAL DEGRADATION; ENVIRONMENTAL MONITORING; PHARMACEUTICAL INDUSTRY; SEASONAL VARIATION; SOLAR RADIATION; WASTEWATER;

MEDITERRANEAN REGION; SPAIN; TAGUS RIVER;

EID: 84874331724     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-012-1099-2     Document Type: Article

References (77)

1. Barone JJ, Roberts HR (1996) Caffeine consumption. Food Chem Toxicol 34: 119-129.
2. Bendz D, Paxeus NA, Ginn TR, Loge FJ (2005) Occurrence and fate of pharmaceuticallyactive compounds in the environment, a case study: Hoje River in Sweden. J Hazard Mater 122: 195-204.
3. Benotti MJ, Brownawell BJ (2007) Distributions of pharmaceuticals in an urban estuary during both dry- and wet-weather conditions. Environ Sci Technol 41: 5795-5802.
4. Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Stanford BD, Snyder SA (2009) Pharmaceuticals and endocrine disrupting compounds in U. S. drinking water. Environ Sci Technol 43: 597-603.
5. Bonvin F, Ruthler R, Chève N, Halder J, Kohn T (2011) Spatial and temporal presence of a wastewater-derived micropollutant plume in Geneva. Environ Sci Technol 45: 4702-4709.
6. Bound JP, Voulvoulis N (2004) Pharmaceuticals in the aquatic environment-a comparison of risk assessment strategies. Chemosphere 56: 1143-1155.
7. Buerge IJ, Poiger T, Muller MD, Buser HR (2003) Caffeine, an anthropogenic marker for wastewater contamination of surface waters. Environ Sci Technol 37: 691-700.
8. Camacho-Munoz D, Martin J, Santos JL, Aparicio I, Alonso E (2010) Occurrence, temporal evolution and risk assessment of pharmaceutically active compounds in Doñana Park (Spain). J Hazard Mater 183: 602-608.
9. Carballa M, Omil F, Lema JM, Llompart M, Garcia-Jares C, Rodriguez I et al (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38: 2918-2926.
10. Carballa M, Omil F, Lema JM, Llompart M, Garcia C, Rodriguez I, Gomez M, Ternes T (2005) Behaviour of pharmaceuticals and personal care products in a sewage treatment plant of northwest Spain. Water Sci Technol 52: 29-35.
11. Carrasco P, Astasio P, Ortega P, Jimenez R, Gil A (2001) Factores asociados al consumo de fármacos psicotropos en la población adulta española. Datos obtenidos a partir de las Encuestas Nacionales de Salud de España de los años 1993, 1995 y 1997. Medina Clinica 116: 324-329.
12. Catalá M, González Alonso S, Montero JC, Valcarcel Y (2012) Letter to the Editor Response to the letter to the editor by Maraver et al. (2012). Nicotine traces detected in bottled mineral water. Sci Total Environ 424: 358-359.
13. Choi K, Kim Y, Jung J, Kim MH, Kim CS, Kim NH et al (2008) Occurrences and ecological risks of roxithromycin, trimethoprim, and chloramphenicol in the Han River, Korea. Environ Toxicol Chem 27: 711-719.
14. Comerton AM, Andrews RC, Bagley DM (2009) Practical overview of analytical methods for endocrine-disrupting compounds, pharmaceuticals and personal care products in water and wastewater. Philos Transact A Math Phys Eng Sci 367: 3923-3939.
15. Conley JM, Symes SJ, Schorr MS, Richards SM (2008) Spatial and temporal analysis of pharmaceutical concentrations in the upper Tennessee River basin. Chemosphere 73: 1178-1187.
16. Daneshvar A, Svanfelt J, Kronberg L, Prevost M, Weyhenmeyer GA (2010a) Seasonal variations in the occurrence and fate of basic and neutral pharmaceuticals in a Swedish river-lake system. Chemosphere 80: 301-309.
17. Daneshvar A, Svanfelt J, Kronberg L, Weyhenmeyer GA (2010b) Winter accumulation of acidic pharmaceuticals in a Swedish river. Environ Sci Pollut Res Int 17: 908-916.
18. Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107: 907-938.
19. Environment Canada (2007) Pharmaceuticals and personal care products in the Canadian environment: research and policy directions. Workshop Proceedings Minister of Public Works and Government Services Canada. NWRI Scientific Assessment Report No 8. Burlington, Ontario. http://www. ec. gc. ca/inre-nwri/C00A589F-1CB5-4B81-93C9-8305E2BFEED3/ppcp-ppsp_2007-e. pdf.
20. European Environment Agency (2010) Pharmaceuticals in the environment Results of an EEA workshop. EEA Technical report No 1/2010. Copenhagen. http://www. eea. europa. eu/publications/pharmaceuticals-in-the-environment-result-of-an-eea-workshop/at_download/file.
21. Farmaindustria (2002) La industria farmacéutica en cifras. http://www. farmaindustria. es/idc/groups/public/documents/publicaciones/farma_002843. pdf. Accessed Feb 2010).
22. Fent K, Weston AA, Caminada D (2006) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76: 122-159.
23. Fernandez C, Gonzalez-Doncel M, Pro J, Carbonell G, Tarazona JV (2010) Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization. Sci Total Environ 408: 543-551.
24. Focazio MJ, Kolpin DW, Barnes KK, Furlong ET, Meyer MT, Zaugg SD et al (2008) A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States-(II) untreated drinking water sources. Sci Total Environ 402: 201-216.
25. García del Pozo J, Ramos SE, De Abajo F, Mateos CR (2004) Utilización de los antihipertensivos en España (1995-2001). Rev Esp Cardiol 57: 241-249.
26. Glassmeyer ST, Hinchey EK, Boehme SE, Daughton CG, Ruhoy IS, Conerly O et al (2009) Disposal practices for unwanted residential medications in the United States. Environ Int 35: 566-572.
27. González Alonso S, Catalá M, Romo R, Rodríguez J, Gil A, Valcárcel Y (2010) Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan Area (Spain). Environ Int 36: 195-210.
28. Gracia-Lor E, Sancho JV, Serrano R, Hernández F (2012) Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia. Chemosphere 87: 453-562.
29. Gros M, Petrovic M, Barcelo D (2007) Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (northeast Spain). Environ Toxicol Chem 26: 1553-1562.
30. Heberer T (2002) Occurence, fate and removal of pharmaceuticals residues in the aquatic environment: a review of recent research date. Toxciol Lett 131: 5-17.
31. Hignite C, Azarnoff DL (1977) Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicyclic acid in sewage water effluent. Life Sci 20: 337-341.
32. Hollender J, Zimmermann SG, Koepke S, Krauss M, McArdell CS, Ort C et al (2009) Elimination of organic micropollutants in a municipal wastewater treatment plant upgraded with a full-scale post-ozonation followed by sand filtration. Environ Sci Technol 43: 7862-7869.
33. Hua W, Bennett ER, Letcher RJ (2006) Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. Water Res 40: 2259-2266.
34. Huerta-Fontela M, Galceran MT, Ventura F (2007) Ultraperformance liquid chromatography-tandem mass spectrometry analysis of stimulatory drugs of abuse in wastewater and surface waters. Anal Chem 79: 3821-3829.
35. Huerta-Fontela M, Galceran MT, Martin-Alonso J, Ventura F (2008a) Occurrence of psychoactive stimulatory drugs in wastewaters in north-eastern Spain. Sci Total Environ 397: 31-40.
36. Huerta-Fontela M, Galceran MT, Ventura F (2008b) Stimulatory drugs of abuse in surface waters and their removal in a conventional drinking water treatment plant. Environ Sci Technol 42: 6809-6816.
37. Huerta-Fontela M, Galceran MT, Ventura F (2011) Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water Res 45: 1432-1442.
38. IMS Health (2006) IMS Health Service Team. Available from: http://www. imshealth. com Accesed November 2011.
39. INEbase (2009) National Statistics Institute on-line database. Accessed November 2011.
40. Infante C, Rubio-Colavida JM (2004) La prevalencia del consumo de tabaco en España. Adicciones 16: 59-73.
41. Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ (2008) The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res 42: 3498-3518.
42. Kolpin DW, Frulong ET, Meyer MT, Thurman EM, Zauggs SD, Barber LB, Bouxton HT (2002) Pharmaceuticals, hormones and other organic wastewater contaminants in US stream (1999-2000). A national reconnaissance. Environ Sci Technol 36: 1202-1211.
43. Kolpin DW, Skopec M, Meyer MT, Furlong ET, Zaugg SD (2004) Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions. Sci Total Environ 328: 119-130.
44. Kumar A, Xagoraraki I (2010) Human health risk assessment of pharmaceuticals in water: an uncertainty analysis for meprobamate, carbamazepine, and phenytoin. Regul Toxicol Pharmacol 57: 146-156.
45. Lapworth DJ, Baran N, Stuart ME, Ward RS (2012) Emerging organic contaminants in groundwater: a review of sources, fate and occurrence. Environ Int 163: 287-303.
46. Loraine GA, Pettigrove ME (2006) Seasonal variation in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in southern California. Environ Sci Technol 40: 687-695.
47. Lorenzo-Lacruz J, Vicente-Serrano SM, López-Moreno JI, Begueríab S, García-Ruiz JM, Cuadrat JM (2010) The impact of droughts and water management on various hydrological systems in the headwaters of the Tagus River (central Spain). J Hydrol 386: 13-26.
48. Martinez Bueno M, Hernando M, Herrera S, Gómez M, Fernández-Alba AR, Bustamante I et al (2010) Pilot survey of chemical contaminants from industrial and human activities in river waters in Spain. Int J Environ Anal Chem 90: 321-343.
49. McArdell CS, Molnar E, Suter MJ, Giger W (2003) Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt Valley watershed, Switzerland. Environ Sci Technol 37: 5479-5486.
50. Metcalfe CD, Miao XS, Koenig BG, Struger J (2003) Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ Toxicol Chem 22: 2881-2889.
51. Miguel A, Martínez M, Vendrell J, Armando Y, Puig J (2001) Cambios estacionales de la presión arterial en la hipertensión leve. Medicina Clínica 117: 372-374.
52. Mompelat S, Le BB, Thomas O (2009) Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ Int 35: 803-814.
53. Radjenovic J, Petrovic M, Barcelo D (2007) Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal Bioanal Chem 387: 1365-1377.
54. Radjenovic J, Petrovic M, Ventura F, Barcelo D (2008) Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. Water Res 42: 3601-3610.
55. Richardson SD, Ternes TA (2011) Water analysis: emerging contaminants and current issues. Anal Chem 83: 4614-4648.
56. Rodriguez-Gil JL, Catalá M, González Alonso S, Romo Maroto R, Valcarcel Y, Segura Y et al (2010) Heterogeneous photo-Fenton treatment for the reduction of pharmaceutical contamination in Madrid rivers and ecotoxicological evaluation by a miniaturized fern spores bioassay. Chemosphere 80: 381-388.
57. Sanderson H (2011) Presence and risk assessment of pharmaceuticals in surface water and drinking water. Water Sci Technol 63: 2143-2148.
58. Sans S, Paluzie G, Puig T, Balaña L, Balaguer-Vintró I (2002) Prevalencia del consumo de medicamentos en la población adulta de Cataluña. Gac Sanit 16: 121-130.
59. Segura J (2004) Variación estacional de los niveles plasmáticos de colesterol: implicaciones terapéuticas y posibles mecanismos. Hipertensión 21: 278-279.
60. Stackelberg PE, Furlong ET, Meyer MT, Zaugg SD, Henderson AK, Reissman DB (2004) Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci Total Environ 329: 99-113.
61. Stackelberg PE, Gibs J, Furlong ET, Meyer MT, Zaugg SD, Lippincott RL (2007) Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. Sci Total Environ 377: 255-272.
62. Sui Q, Huang J, Deng S, Chen W, Yu G (2011) Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment process. Environ Sci Technol 45: 3341-3348.
63. Supratik K, Kunal R (2012) Risk assessment for ecotoxicity of pharmaceuticals-an emerging issue. Expert Opin Drug Saf 11: 235-274.
64. Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32: 3245-3260.
65. Ternes TA, Meisenheimer M, McDowell D, Sacher F, Brauch HJ, Haist-Gulde B et al (2002) Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 36: 3855-3863.
66. Ternes TA, Stuber J, Herrmann N, McDowell D, Ried A, Kampmann M, Teiser B (2003) Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Water Res 37: 1976-1982.
67. Togola A, Budzinski H (2008) Multi-residue analysis of pharmaceutical compounds in aqueous samples. J Chromatogr (A) 1177: 150-158.
68. United States Environmental Protection Agency (2009) Contaminant Candidate List 3 (CCL3). EPA 815-R-09-008. Washington, DC.
69. Valcarcel Y, González Alonso S, Rodriguez-Gil JL, Romo R, Gil A, Catala M (2011a) Analysis of the presence of cardiovascular and analgesic/anti-inflammatory/antipyretic pharmaceuticals in river- and drinking-water of the Madrid Region in Spain. Chemosphere 82: 1062-1071.
70. Valcarcel Y, González Alonso S, Rodriguez-Gil JL, Gil A, Catala M (2011b) Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk. Chemosphere 84: 1336-1348.
71. Vieno NM, Tuhkanen T, Kronberg L (2005) Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 39: 8220-8226.
72. Wang C, Shi H, Adams CD, Gamagedara S, Stayton I, Timmons T et al (2011) Investigation of pharmaceuticals in Missouri natural and drinking water using high performance liquid chromatography-tandem mass spectrometry. Water Res 45: 1818-1828.
73. Westerhoff P, Yoon Y, Snyder S, Wert E (2005) Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ Sci Technol 39: 6649-6663.
74. Zhang Y, Geissen SU, Gal C (2008) Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 73: 1151-1161.
75. Zimmermann SG, Wittenwiler M, Hollender J, Krauss M, Ort C, Siegrist H, von Gunten U (2011) Kinetic assessment and modeling of an ozonation step for full-scale municipal wastewater treatment: micropollutant oxidation, by-product formation and disinfection. Water Res 45: 605-617.
76. Zuccato E, Castiglioni S, Farrellin R, Reitano G, Bagnati R, Chiabrando C, Pomati F, Rosseti C, Calamaria D (2005) Pharmaceuticals in the environment in Italy: causes, occurences, effects and control. Environ Sci Pollut Res Int 13: 15-25.
77. Zwiener C (2007) Occurrence and analysis of pharmaceuticals and their transformation products in drinking water treatment. Anal Bioanal Chem 387: 1159-1162.